We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: Extended investment: Withheld
Over the past 8 years, Advatech Healthcare has created Hippo, a proven disabled and non-emergency patients transportation services (NEPTS) in the Essex area. Due to its dependability and efficiency, Hippo is now poised to become the UK's best national wheelchair accessible healthcare services on a wearable technology platform. According to the Office for Technology Statistics data, there are 13.37 million people disabled in the UK who lack dedicated non-emergency transportation. Hippo could save the National Health Service (NHS) up to 60% on transportation costs increasing faster hospital bed rotation and providing dedicated transportation for disabled and non-emergency patients with a medically trained staff. It also offers medical and technological necessities not offered by many leading operators. Currently, the company operates within the Essex area. By the end of 2020, the company aims to commence seven new contracts it has signed with the NHS. It also signed a deal with Cambridge Adult Social Care that is expected to close, within a 5-year term and generate over £200,000 per year.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
The Landsite is the UK's first online property portal that connects various entities within the property industry such as developers, legal services, insurance advisors and architects, to one another, simplifying the process of finding and buying a property. By registering with The Landsite, a business/professional can list their business as operating in a specific region of the country and appear against all property searches that take place in that same region. The user then needs to put in their postcode or address and can then access properties within that region, as well as, seek available professional guidance to zero in upon a potential purchase. The platform also has an insights page that aims to become a recruitment, training and educational hub for the property industry. The company will use the investment to grow its business across different verticals.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
EV Hub plans to offer fast charging for fleets of electric cars, vans, and couriers at sites with 15-30 bays each. The company uses the latest stable technology that needs only c.30 minutes per charge in comparison to 1-2 hours ‘Fast’ chargers and overnight for ‘Slow’ home/work charging. EV Hub's goal is to start with London’s 3,000 electric taxis, and it will expand quickly to serve vans, hire cars, minicabs, and couriers. With the proceeds, the company will lease and run two first flagship, high-traffic sites, King’s Cross and Heathrow Airport, which will help boost the working capital to profitability.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
BMM Networks is a company specialising in providing electric vehicle charging solutions throughout the UK. Currently, there are about 250,000 electric vehicles (EV) in the UK, with the hope that it will increase to 1 million by 2022. But this transition requires dependable and safe On-Street and Workplace charging stations. The UK Government, through the Office for Low Emission Vehicles (OLEV), has dedicated over £900 million of funding to expanding EV usage, of which £500 million is in scope for the BMM charging point business model. With the help of its delivery partner, BMM Energy Solutions Limited, BMM Networks has engaged with several local authorities to develop charging solutions. The company is one of the 10 approved framework providers for OLEV funded projects. Within this setup, OLEV will fund 75% of the installation cost or £5,000 for each charging point, leaving BMM to fund the balance of £1,250 per charger. This will enhance the coverage of charging points thereby boosting EV sales. The company is seeking £1.375 million of equity funding to boost its brand identity and business opportunities.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
DMD has made its digital content distribution enterprise in the last two years. Along with that, it has developed a global cinema TVOD (Transactional Video On Demand product). The company has built a long-term distribution partnership with OTT companies, telephone/IPTV and major cable that lead the wealthiest portion of the Pay TV market, providing service to 17 million two-way homes in 19 nations in Latin America. DMD's revenue has increased by 93% YoY 2017-2018, which will help the company in reaching EBITDA breakeven in Q3 of 2019. DMD has established relationships with distributors and leading sales agents in Europe and the USA. With the proceeds, the company will acquire bigger commercial films, increase its global footprint by launching the company in Asia, Africa, and Europe, and supplement its current output with classic titles.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £145,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph